<DOC>
	<DOCNO>NCT00544037</DOCNO>
	<brief_summary>To assess long-term effect early therapeutic intervention , i.e . within two year follow first clinical demyelinate event suggestive MS .</brief_summary>
	<brief_title>BENEFIT Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>All patient randomize treat least study 304747 Medical , psychiatric condition compromise patient 's ability understand purpose study</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>